# Pharmacokinetics and Safety of Ticarcillin-clavulanate in Infants

> **NCT01229046** · PHASE1 · WITHDRAWN · sponsor: **Phillip Brian Smith**

## Conditions studied

- Sepsis

## Interventions

- **DRUG:** Ticarcillin-clavulanic acid

## Key facts

- **NCT ID:** NCT01229046
- **Lead sponsor:** Phillip Brian Smith
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2010-09
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No enrollment occured. Subjects will be enrolled under a new protocol.
- **Last updated:** 2012-11-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01229046

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01229046, "Pharmacokinetics and Safety of Ticarcillin-clavulanate in Infants". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01229046. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*